BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 18519784)

  • 1. Retinoblastoma RB94 enhances radiation treatment of head and neck squamous cell carcinoma.
    Araki K; Ahmad SM; Li G; Bray DA; Saito K; Wang D; Wirtz U; Sreedharan S; O'Malley BW; Li D
    Clin Cancer Res; 2008 Jun; 14(11):3514-9. PubMed ID: 18519784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of adenovirus-mediated retinoblastoma 94 in the treatment of head and neck cancer.
    Li D; Day KV; Yu S; Shi G; Liu S; Guo M; Xu Y; Sreedharan S; O'Malley BW
    Cancer Res; 2002 Aug; 62(16):4637-44. PubMed ID: 12183420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutant Nbs1 enhances cisplatin-induced DNA damage and cytotoxicity in head and neck cancer.
    Tran HM; Shi G; Li G; Carney JP; O'Malley B; Li D
    Otolaryngol Head Neck Surg; 2004 Oct; 131(4):477-84. PubMed ID: 15467621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination nonviral interleukin 2 gene therapy and external-beam radiation therapy for head and neck cancer.
    Bray D; Yu SZ; Koprowski H; Rhee J; Kumar S; Pericle F; Suntharalingam M; Van Echo DA; Li D; O'Malley BW
    Arch Otolaryngol Head Neck Surg; 2003 Jun; 129(6):618-22. PubMed ID: 12810463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conditionally replicating adenovirus improves gene replication efficiency and anticancer effect of E1-deleted adenovirus carrying TRAIL in head and neck squamous cell carcinoma.
    Shim SH; Lee CT; Hun Hah J; Lee JJ; Park SW; Heo DS; Sung MW
    Cancer Sci; 2010 Feb; 101(2):482-7. PubMed ID: 19922505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinoblastoma 94 enhances radiation treatment of esophageal squamous cell carcinoma in vitro and in vivo.
    Zhang H; Li J; Wang YY; Meng AM; Liu Q; Wang L; Chen FH; Wang XC; Zhai ZB; Fu Y; Wang Q
    J Radiat Res; 2012; 53(1):117-24. PubMed ID: 22302052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptosis induction by E2F-1 via adenoviral-mediated gene transfer results in growth suppression of head and neck squamous cell carcinoma cell lines.
    Liu TJ; Wang M; Breau RL; Henderson Y; El-Naggar AK; Steck KD; Sicard MW; Clayman GL
    Cancer Gene Ther; 1999; 6(2):163-71. PubMed ID: 10195883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxicity and antiangiogenesis by fibroblast growth factor 2-targeted Ad-TK cancer gene therapy.
    Saito K; Khan K; Sosnowski B; Li D; O'Malley BW
    Laryngoscope; 2009 Apr; 119(4):665-74. PubMed ID: 19213040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Head and neck cancer radiosensitization by the novel poly(ADP-ribose) polymerase inhibitor GPI-15427.
    Khan K; Araki K; Wang D; Li G; Li X; Zhang J; Xu W; Hoover RK; Lauter S; O'Malley B; Lapidus RG; Li D
    Head Neck; 2010 Mar; 32(3):381-91. PubMed ID: 19672867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Construction of autocatalytic caspase-3 driven by amplified human telomerase reverse transcriptase promoter and its enhanced efficacy of inducing apoptosis in human ovarian carcinoma].
    Song Y; Shen K; He CX
    Zhonghua Fu Chan Ke Za Zhi; 2007 Sep; 42(9):617-22. PubMed ID: 17983518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. All-trans-retinoic acid enhances the effect of adenovirus-mediated wild-type p53 gene transfer in head and neck squamous cell carcinoma.
    Nakashima T; Sun SY; Lotan R; Fujiwara T; Yasumatsu R; Komiyama S; Clayman GL
    Laryngoscope; 2001 Aug; 111(8):1459-64. PubMed ID: 11568584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined radiation sensitizing and anti-angiogenic effects of ionizing radiation and the protease inhibitor ritonavir in a head and neck carcinoma model.
    Maggiorella L; Wen B; Frascogna V; Opolon P; Bourhis J; Deutsch E
    Anticancer Res; 2005; 25(6B):4357-62. PubMed ID: 16309240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Granulocyte-macrophage colony-stimulating factor in a combination gene therapy strategy for head and neck cancer.
    Day KV; Li D; Liu S; Guo M; O'Malley BW
    Laryngoscope; 2001 May; 111(5):801-6. PubMed ID: 11368071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiosensitization of squamous cell carcinoma by the alkylphospholipid perifosine in cell culture and xenografts.
    Vink SR; Lagerwerf S; Mesman E; Schellens JH; Begg AC; van Blitterswijk WJ; Verheij M
    Clin Cancer Res; 2006 Mar; 12(5):1615-22. PubMed ID: 16533789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenoviral-mediated retinoblastoma 94 produces rapid telomere erosion, chromosomal crisis, and caspase-dependent apoptosis in bladder cancer and immortalized human urothelial cells but not in normal urothelial cells.
    Zhang X; Multani AS; Zhou JH; Shay JW; McConkey D; Dong L; Kim CS; Rosser CJ; Pathak S; Benedict WF
    Cancer Res; 2003 Feb; 63(4):760-5. PubMed ID: 12591722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cooperative effects of adenoviral vector-mediated interleukin 12 gene therapy with radiotherapy in a preclinical model of metastatic prostate cancer.
    Fujita T; Timme TL; Tabata K; Naruishi K; Kusaka N; Watanabe M; Abdelfattah E; Zhu JX; Ren C; Ren C; Yang G; Goltsov A; Wang H; Vlachaki MT; Teh BS; Butler EB; Thompson TC
    Gene Ther; 2007 Feb; 14(3):227-36. PubMed ID: 17024109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 mediated sensitization of squamous cell carcinoma of the head and neck to radiotherapy.
    Pirollo KF; Hao Z; Rait A; Jang YJ; Fee WE; Ryan P; Chiang Y; Chang EH
    Oncogene; 1997 Apr; 14(14):1735-46. PubMed ID: 9135075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetically targeted radiotherapy of head and neck squamous cell carcinoma using the sodium-iodide symporter (NIS).
    Gaut AW; Niu G; Krager KJ; Graham MM; Trask DK; Domann FE
    Head Neck; 2004 Mar; 26(3):265-71. PubMed ID: 14999802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FasL gene therapy: a new therapeutic modality for head and neck cancer.
    ElOjeimy S; McKillop JC; El-Zawahry AM; Holman DH; Liu X; Schwartz DA; Day TA; Dong JY; Norris JS
    Cancer Gene Ther; 2006 Aug; 13(8):739-45. PubMed ID: 16543918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. eIF4E-targeted suicide gene therapy in a minimal residual mouse model for metastatic soft-tissue head and neck squamous cell carcinoma improves disease-free survival.
    Siegele B; Cefalu C; Holm N; Sun G; Tubbs J; Meschonat C; Odaka Y; DeBenedetti A; Ghali GE; Chu Q; Mathis JM; Li BD
    J Surg Res; 2008 Jul; 148(1):83-9. PubMed ID: 18570935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.